Nxera Pharma Co.,Ltd.

4565

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-07FY2026 Q2

Revenue

334.3100M JPY

YoY +7.1%

Operating Income

18.8100M JPY

YoY +168.3%

Net Income

-78100M JPY

YoY -138.4%

EPS

17.5JPY

YoY +150.4%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

296.1億円

190.8億円

85.4億円

-19.9億円

-125.3億円

Rev: 177.1億円Op: 37.8億円NI: 10.2億円

Rev: 155.7億円Op: 34.4億円NI: 3.8億円

Rev: 127.7億円Op: -95.3億円NI: -71.9億円

Rev: 288.4億円Op: -54.2億円NI: -48.4億円

Rev: 296.1億円Op: -84.6億円NI: -125.3億円

2021/FY2022/FY2023/FY2024/FY2025/FY

Full-Year Progress

FY2026 Q2

Net Income-

Revenue Progress189.100M

Revenue Forecast-

Net Income Progress15.900M

Net Income Forecast-

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan